| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities | |||||||||
Net income | |||||||||
31,979 | 26,379 | 16,292 | 15,951 | 12,794 | 10,473 | 9,549 | 35,490 | 5,829 | -17,854 |
Adjustments to reconcile net income to net cash from operating activities: | |||||||||
Depreciation and amortization | |||||||||
2,212 | 2,562 | 2,285 | 2,805 | 2,969 | 3,139 | 3,067 | 2,970 | 3,117 | 2,956 |
Stock compensation expense | |||||||||
427 | 452 | 465 | 536 | 478 | 338 | 160 | 9 | 66 | 138 |
Tax effect of vested stock awards | |||||||||
- | - | - | -143 | -53 | -63 | 0 | 0 | - | - |
Tax effect of expired common stock options and warrants | |||||||||
- | - | - | -219 | -280 | 0 | - | - | - | - |
Tax effect of expired common stock warrants | |||||||||
- | - | - | - | - | - | 0 | - | - | - |
Provision for loan losses | |||||||||
-450 | 450 | -1,350 | -1,350 | -3,500 | -3,350 | -4,250 | -7,100 | -4,700 | 22,460 |
Origination of loans for sale | |||||||||
82,281 | 33,907 | 56,985 | 103,385 | 99,998 | 73,516 | 107,988 | 140,151 | 84,470 | 93,764 |
Proceeds from sales of loans originated for sale | |||||||||
81,749 | 35,624 | 59,532 | 107,004 | 102,494 | 75,023 | 116,757 | 135,929 | 87,709 | 93,338 |
Net gains on mortgage loans | |||||||||
2,347 | 924 | 1,574 | 3,024 | 2,925 | 1,939 | 2,554 | 2,882 | 1,728 | 1,462 |
Gain on sales of securities | |||||||||
0 | 0 | 3 | 124 | 129 | 75 | 120 | 73 | 0 | 2,715 |
Write-down of other real estate | |||||||||
14 | 323 | 129 | 964 | 724 | 1,623 | 2,922 | 5,236 | 9,879 | 8,277 |
Write-down of other assets held for sale | |||||||||
0 | 234 | 0 | - | - | - | - | - | - | - |
The net gain (loss) resulting from sales and other disposals of other real estate owned and foreclosed assets. | |||||||||
38 | 530 | 557 | - | - | - | - | - | - | - |
Gain / (loss) on sales of other real estate owned | |||||||||
- | - | - | 645 | -926 | 624 | 1,098 | -59 | 1,515 | -167 |
Gain on sale of property | |||||||||
19 | 0 | -240 | 0 | 0 | - | - | -89 | 0 | -574 |
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations, excluding increase (decrease) in valuation allowance. | |||||||||
290 | 502 | - | - | - | - | - | - | - | - |
Deferred income tax expense | |||||||||
- | - | 4,974 | 942 | 3,291 | 2,849 | - | - | - | - |
Change in valuation allowance | |||||||||
0 | -92 | 0 | - | - | - | - | - | - | - |
Change in net deferred tax asset | |||||||||
- | - | - | - | - | - | -4,150 | 18,858 | 0 | - |
FHLB Advance prepayment penalty | |||||||||
- | - | - | - | - | - | - | 322 | 0 | - |
The net change during the reporting period in the amount due from borrowers for interest payments and other operating assets not otherwise defined in the taxonomy. | |||||||||
2,037 | 1,841 | -59 | 1,585 | 1,323 | -1,555 | -124 | -2,149 | - | - |
Change in accrued interest receivable and other assets | |||||||||
- | - | - | - | - | - | - | - | 1,980 | -22,543 |
Earnings in bank-owned life insurance | |||||||||
972 | 942 | 969 | 977 | 663 | 678 | 713 | 847 | 943 | 619 |
Change in accrued expenses and other liabilities | |||||||||
1,193 | 1,161 | 241 | -108 | -910 | 1,737 | -3,694 | 1,153 | 889 | 642 |
Net cash from operating activities | |||||||||
29,720 | 29,635 | 22,779 | 16,928 | 14,001 | - | - | - | 12,153 | 33,533 |
Cash flows from investing activities | |||||||||
Net cash from operating activities | |||||||||
- | - | - | - | - | 16,618 | 16,312 | 13,495 | - | - |
Loan originations and payments, net | |||||||||
-20,805 | 85,816 | 38,629 | 81,988 | 80,350 | 79,524 | - | - | - | - |
Loan originations and payments, net | |||||||||
- | - | - | - | - | - | 7,741 | 8,657 | 96,778 | - |
Change in interest-bearing deposits in other financial institutions | |||||||||
- | - | - | 20,000 | 0 | 5,000 | -25,000 | 0 | 0 | - |
Loan originations and payments, net | |||||||||
- | - | - | - | - | - | - | - | - | -218,715 |
Purchases of securities available for sale | |||||||||
58,403 | 34,391 | 62,093 | 89,159 | 59,807 | 43,882 | 42,594 | 115,248 | 72,944 | 18,985 |
Purchases of securities held to maturity | |||||||||
20,478 | 7,623 | 42,547 | 33,702 | 36,547 | 25,225 | 19,732 | 4,000 | 300 | 0 |
Purchase of bank-owned life insurance | |||||||||
- | - | - | 10,000 | 0 | 0 | - | - | - | - |
Purchase of FHLB stock | |||||||||
- | - | - | 0 | 320 | 2,519 | 0 | 0 | - | - |
Proceeds From [Abstract] | |||||||||
Maturities and calls of securities | |||||||||
72,188 | 31,706 | 40,726 | 68,952 | 47,056 | 22,528 | - | - | - | - |
Maturities and calls of securities | |||||||||
- | - | - | - | - | - | 13,159 | 40,042 | 27,495 | 32,625 |
Maturities and calls of securities held to maturity | |||||||||
- | - | - | - | - | - | - | - | - | 277 |
Sales of securities available for sale | |||||||||
0 | 0 | 5,807 | 11,729 | 20,625 | 10,936 | 5,241 | 4,595 | 0 | 105,553 |
The cash inflow associated with the principal paydowns on securities. | |||||||||
11,053 | 17,322 | 5,992 | 4,159 | 3,670 | 3,642 | 6,100 | 3,884 | 273 | 88 |
The cash inflow from the sale of other real estate and foreclosed assets during the period. | |||||||||
656 | 2,887 | 7,034 | - | - | - | - | - | - | - |
Proceeds from sales of other real estate owned | |||||||||
- | - | - | 5,339 | 11,540 | 12,487 | 16,501 | - | - | - |
Redemption of FHLB stock | |||||||||
- | - | - | - | - | - | - | - | -696 | -343 |
Sales of other real estate | |||||||||
- | - | - | - | - | - | - | 18,729 | 21,540 | 16,003 |
Sale of FHLB stock | |||||||||
- | - | - | - | - | 2,517 | 0 | 0 | - | - |
Sales of premises and equipment held for sale | |||||||||
342 | 0 | 1,742 | 0 | 0 | - | - | - | - | 2,250 |
Death benefit from bank-owned life insurance | |||||||||
- | - | - | 518 | 0 | 0 | - | - | - | - |
Additions to premises and equipment | |||||||||
1,041 | 1,283 | 1,191 | 1,188 | 1,170 | 1,766 | 2,407 | 707 | 1,031 | 620 |
Net cash from investing activities | |||||||||
- | - | - | - | - | -95,806 | -40,991 | -44,048 | - | - |
Net cash from investing activities | |||||||||
25,122 | -77,198 | -83,159 | -105,340 | -95,303 | - | - | - | 72,507 | 356,249 |
Cash flows from financing activities | |||||||||
Change in deposits | |||||||||
76,555 | 97,729 | 130,286 | 13,212 | 129,187 | 56,591 | -36,527 | 70,972 | -13,159 | 18,636 |
Decrease in brokered deposits | |||||||||
- | - | - | - | - | - | - | - | -48,172 | -158,353 |
Proceeds from other borrowed funds | |||||||||
- | - | - | - | - | - | - | - | 10,000 | 120,000 |
Proceeds from issuance of subordinated note | |||||||||
- | - | - | - | - | - | - | - | 1,000 | 0 |
Repayments and maturities of other borrowed funds | |||||||||
30,619 | 52,118 | - | - | - | - | - | 57,103 | 46,733 | 212,687 |
Repayments and maturities of other borrowed funds | |||||||||
- | - | 32,055 | 21,996 | 1,938 | 1,884 | 3,481 | - | - | - |
Proceeds from other borrowed funds | |||||||||
10,000 | 20,000 | 40,000 | 10,000 | 10,000 | 0 | 0 | - | - | - |
Common stock issuance costs | |||||||||
- | - | - | - | - | 102 | 0 | 0 | - | - |
Repurchase of shares for taxes withheld on vested restricted stock | |||||||||
101 | 136 | 183 | 269 | 171 | 106 | 45 | 0 | - | - |
Cash received from option exercises | |||||||||
0 | 386 | 68 | - | - | - | - | - | - | - |
Proceeds from issuance of common stock | |||||||||
- | - | - | 0 | 0 | 4 | 0 | 0 | 19,319 | 0 |
Cash paid related to tax impact of vested stock awards | |||||||||
- | - | - | -143 | -53 | -63 | 0 | 0 | - | - |
Cash dividends paid | |||||||||
9,511 | 8,481 | 6,088 | 4,049 | 3,702 | 2,689 | 0 | 0 | - | - |
Net cash from financing activities | |||||||||
46,324 | 57,380 | 132,028 | -3,245 | 133,323 | - | - | - | -77,745 | -232,404 |
Net change in cash and cash equivalents | |||||||||
101,166 | 9,817 | - | - | - | - | - | - | - | - |
Repurchase shares for taxes withheld on vested restricted stock | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Cash paid in preferred stock exchange | |||||||||
- | - | - | - | - | - | 4,734 | 0 | 0 | - |
Net cash from financing activities | |||||||||
- | - | - | - | - | 51,751 | -44,787 | 13,869 | - | - |
Net change in cash and cash equivalents | |||||||||
- | - | - | - | - | -27,437 | -69,466 | - | - | - |
Net change in cash and cash equivalents | |||||||||
- | - | 71,648 | -91,657 | 52,021 | - | - | -16,684 | 6,915 | 157,378 |
Supplemental cash flow information | |||||||||
Interest paid | |||||||||
12,440 | 9,513 | 5,410 | 4,950 | 5,322 | - | - | - | - | - |
Interest paid | |||||||||
- | - | - | - | - | 5,615 | 11,886 | 8,473 | 13,364 | 24,963 |
Income taxes paid | |||||||||
7,200 | 5,300 | 4,725 | 6,160 | 4,300 | 90 | 120 | 275 | 0 | -18,118 |
Supplemental noncash disclosures: | |||||||||
Additions, transfers from loans | |||||||||
0 | 293 | 120 | 339 | 2,520 | 4,932 | 3,539 | - | - | - |
Transfers from loans to other real estate | |||||||||
- | - | - | - | - | - | - | 9,168 | 38,358 | 45,248 |
The fair value of securities purchased not yet settled in noncash investing and financing activities. | |||||||||
9,901 | 0 | - | - | - | - | 1,626 | 1,626 | 0 | - |
Value transferred from premises and equipment to other assets held for sale in noncash transactions. | |||||||||
0 | 557 | 0 | - | - | - | - | - | - | - |
Conversion of 300 shares of Preferred Series B to 50,000 shares of common stock | |||||||||
- | - | - | - | - | - | 300 | 0 | - | - |
Exchange of 31,290 shares of Preferred Series A for 5,973,519 shares of common stock | |||||||||
- | - | - | - | - | - | 30,604 | 0 | - | - |
Exchange of 31,290 shares of Preferred Stock Series A to 5,973,519 shares of common stock | |||||||||
- | - | - | - | - | - | - | - | 0 | - |
Exchange of 2,300 shares of Preferred Series B for 457,159 shares of common stock | |||||||||
- | - | - | - | - | - | 2,260 | 0 | 0 | - |
Transfer from fixed assets to other real estate | |||||||||
- | - | - | - | - | - | - | - | - | 1,676 |
Conversion of subordinated note to 491,830 shares of common stock | |||||||||
- | - | - | - | - | - | - | - | 1,003 | 0 |
Conversion of 300 shares of Preferred Stock Series B to 50,000 shares of common stock | |||||||||
- | - | - | - | - | - | - | - | 0 | - |